India Pharmaceutical Industry India's New Drug–Pricing Policy Faces Opposition

Editor: Dominik Stephan

India's government faces strong opposition for its new drug–pricing policy draft: Although manufacturers welcome the plans, health organisations fear rising prices for medicine in India.

Related Companies

(Picture: PROCESS India)
(Picture: PROCESS India)

New Delhi/India – The Indian government's new drug pricing policy draft faces opposition for fears that medicine prices could increase. Also the World Health Organisation, a member of the Parliament's standing committee on health, experts and health group, submitted its resentment against the plans.

India's government recently issued the 'National Pharmaceuticals Pricing Policy Draft' that plans to cap the prices of 348 essential drugs and their combinations at the average price of the top three brands in the respective segments. Most Indian manufacturers of pharmaceuticals welcome this plan, although with some slight changes.